Dr. Wagner is professor of Pharmaceutical Biotechnology at Ludwig-Maximilians-Universität Munich and member of the Munich Center for Nanoscience. He coordinates ‘Biomedical Nanotechnologies’ of the Excellence Cluster ‘Nanosystems Initiative Munich’.

After a Ph.D. in Chemistry from the Technical University of Vienna and a postdoctoral stay at the ETH Zurich, he was Group Leader at the IMP Vienna and Director for Cancer Vaccines at Boehringer Ingelheim Austria. Dr. Wagner has authored more than 390 publications (h-index 70). He has been Board member of the German Society for Gene Therapy, Committee member of ASGCT, and BSA member of the CRS.